Advanced search
1 file | 1.17 MB Add to list

Next-generation sequencing : an eye-opener for the surveillance of antiviral resistance in influenza

(2020) TRENDS IN BIOTECHNOLOGY. 38(4). p.360-367
Author
Organization
Abstract
Next-generation sequencing (NGS) can enable a more effective response to a wide range of communicable disease threats, such as influenza, which is one of the leading causes of human morbidity and mortality worldwide. After vaccination, antivirals are the second line of defense against influenza. The use of currently available antivirals can lead to antiviral resistance mutations in the entire influenza genome. Therefore, the methods to detect these mutations should be developed and implemented. In this Opinion, we assess how NGS could be implemented to detect drug resistance mutations in clinical influenza virus isolates.
Keywords
VIRUSES, MUTATIONS, SCALE

Downloads

  • 1-s2.0-S0167779919302410-main.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 1.17 MB

Citation

Please use this url to cite or link to this publication:

MLA
Van Poelvoorde, Laura, et al. “Next-Generation Sequencing : An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza.” TRENDS IN BIOTECHNOLOGY, vol. 38, no. 4, 2020, pp. 360–67, doi:10.1016/j.tibtech.2019.09.009.
APA
Van Poelvoorde, L., Saelens, X., Thomas, I., & Roosens, N. H. (2020). Next-generation sequencing : an eye-opener for the surveillance of antiviral resistance in influenza. TRENDS IN BIOTECHNOLOGY, 38(4), 360–367. https://doi.org/10.1016/j.tibtech.2019.09.009
Chicago author-date
Van Poelvoorde, Laura, Xavier Saelens, Isabelle Thomas, and Nancy H Roosens. 2020. “Next-Generation Sequencing : An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza.” TRENDS IN BIOTECHNOLOGY 38 (4): 360–67. https://doi.org/10.1016/j.tibtech.2019.09.009.
Chicago author-date (all authors)
Van Poelvoorde, Laura, Xavier Saelens, Isabelle Thomas, and Nancy H Roosens. 2020. “Next-Generation Sequencing : An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza.” TRENDS IN BIOTECHNOLOGY 38 (4): 360–367. doi:10.1016/j.tibtech.2019.09.009.
Vancouver
1.
Van Poelvoorde L, Saelens X, Thomas I, Roosens NH. Next-generation sequencing : an eye-opener for the surveillance of antiviral resistance in influenza. TRENDS IN BIOTECHNOLOGY. 2020;38(4):360–7.
IEEE
[1]
L. Van Poelvoorde, X. Saelens, I. Thomas, and N. H. Roosens, “Next-generation sequencing : an eye-opener for the surveillance of antiviral resistance in influenza,” TRENDS IN BIOTECHNOLOGY, vol. 38, no. 4, pp. 360–367, 2020.
@article{8646230,
  abstract     = {Next-generation sequencing (NGS) can enable a more effective response to a wide range of communicable disease threats, such as influenza, which is one of the leading causes of human morbidity and mortality worldwide. After vaccination, antivirals are the second line of defense against influenza. The use of currently available antivirals can lead to antiviral resistance mutations in the entire influenza genome. Therefore, the methods to detect these mutations should be developed and implemented. In this Opinion, we assess how NGS could be implemented to detect drug resistance mutations in clinical influenza virus isolates.},
  author       = {Van Poelvoorde, Laura and Saelens, Xavier and Thomas, Isabelle and Roosens, Nancy H},
  issn         = {0167-7799},
  journal      = {TRENDS IN BIOTECHNOLOGY},
  keywords     = {VIRUSES,MUTATIONS,SCALE},
  language     = {eng},
  number       = {4},
  pages        = {360--367},
  title        = {Next-generation sequencing : an eye-opener for the surveillance of antiviral resistance in influenza},
  url          = {http://dx.doi.org/10.1016/j.tibtech.2019.09.009},
  volume       = {38},
  year         = {2020},
}

Altmetric
View in Altmetric
Web of Science
Times cited: